Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schaapveld

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Lancet (London, England)|June 28, 2005
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphomaA Diepstra, M Niens, E Vellenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patientsJ L Westra, H Hollema, M Schaapveld, et al.
Gynecologic Oncology|March 26, 2005
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinomaF Y F L De Vos, A M E Bos, M Schaapveld, et al.
British Journal of Cancer|October 13, 2012
Risk and prognostic significance of metachronous contralateral testicular germ cell tumoursM Schaapveld, A W van den Belt-Dusebout, J A Gietema, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancerG A P Hospers, M Schaapveld, J W R Nortier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
No association between the Arg201Gly polymorphism of the DCC gene and colorectal cancerM M de Jong, G J te Meerman, W T A van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel studyA K L Reyners, L de Munck, F L G Erdkamp, et al.
ESMO Open|February 13, 2024
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphomaY M Geurts, S I M Neppelenbroek, B M P Aleman, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Lancet (London, England)|June 28, 2005
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphomaA Diepstra, M Niens, E Vellenga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patientsJ L Westra, H Hollema, M Schaapveld, et al.
Gynecologic Oncology|March 26, 2005
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinomaF Y F L De Vos, A M E Bos, M Schaapveld, et al.
British Journal of Cancer|October 13, 2012
Risk and prognostic significance of metachronous contralateral testicular germ cell tumoursM Schaapveld, A W van den Belt-Dusebout, J A Gietema, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancerG A P Hospers, M Schaapveld, J W R Nortier, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
No association between the Arg201Gly polymorphism of the DCC gene and colorectal cancerM M de Jong, G J te Meerman, W T A van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2012
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel studyA K L Reyners, L de Munck, F L G Erdkamp, et al.
ESMO Open|February 13, 2024
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphomaY M Geurts, S I M Neppelenbroek, B M P Aleman, et al.
Pageof 4